Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay

ACS Chemical Biology

Volumn 7, Issue 3, 2012, Pages 526-534

  Baughman, Brandi M ^a,b   Jake Slavish, P ^b   Dubois, Rebecca M ^b   Boyd, Vincent A ^b   White, Stephen W ^a,b   Webb, Thomas R ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIOXO 4 PHENYLBUTANOIC ACID; 4 PHENYLBUTYRIC ACID; 4 SUBSTITUTED 2,4 DIOXOBUTANOIC ACID INHIBITOR; BUTYRIC ACID; ENDONUCLEASE; ESTERASE INHIBITOR; L 742001; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; DRUG IDENTIFICATION; FLUORESCENCE POLARIZATION IMMUNOASSAY; HIGH THROUGHPUT SCREENING; PRIORITY JOURNAL;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDONUCLEASES; ENZYME INHIBITORS; FLUORESCENCE POLARIZATION; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; ORTHOMYXOVIRIDAE; STRUCTURE-ACTIVITY RELATIONSHIP;

ORTHOMYXOVIRIDAE;

EID: 84858635392     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb200439z     Document Type: Article

References (63)

1. Garibaldi, R. A. (1985) Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact Am. J. Med. 78, 32-37 (Pubitemid 15036955)
2. World Health Organization. ((2011) North America Circulation of Influenza Viruses; Influenza update, 21 April 2011; Geneva, Switzerland.
3. Patterson, K. D. and Pyle, G. F. (1991) The geography and mortality of the 1918 influenza pandemic Bull. Hist. Med. 65, 4-21
4. Demicheli, V., Rivetti, D., Deeks, J. J., and Jefferson, T. O. (2004) Vaccines for preventing influenza in healthy adults, Cochrane Database Syst. Rev., CD001269.
5. Patriarca, P. A., Weber, J. A., Meissner, M. K., Stricof, R. L., Dateno, B., Braun, J. E., Arden, N. H., and Kendal, A. P. (1985) Use of influenza vaccine in nursing homes J. Am. Geriatr. Soc. 33, 463-466 (Pubitemid 15037136)
6. Nichol, K. L., Wuorenma, J., and von Sternberg, T. (1998) Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens Arch. Intern. Med. 158, 1769-1779
7. Glezen, W. P., Decker, M., and Perrotta, D. M. (1987) Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981 Am. Rev. Respir. Dis. 136, 550-555 (Pubitemid 18007351)
8. Stiver, G. (2003) The treatment of influenza with antiviral drugs Can. Med. Assoc. J. 168, 49-56
9. Hayden, F. (2009) Developing new antiviral agents for influenza treatment: what does the future hold? Clin. Infect. Dis. 48 (Suppl 1) S3-S13
10. De Clercq, E. and Field, H. J. (2008) Antiviral Chemistry & Chemotherapys current antiviral agents FactFile 2008 (2nd edition): RNA viruses Antiviral Chem. Chemother. 19, 63-74
11. Lüscher-Mattli, M. (2000) Influenza chemotherapy: A review of the present state of art and of new drugs in development Arch. Virol. 145, 2233-2248 (Pubitemid 32040086)
12. Moscona, A. (2008) Medical management of influenza infection Annu. Rev. Med. 59, 397-413 (Pubitemid 351287945)
13. Wilson, J. C. and von Itzstein, M. (2003) Recent strategies in the search for new anti-influenza therapies Curr. Drug Targets 4, 389-408 (Pubitemid 36758318)
14. Beigel, J. and Bray, M. (2008) Current and future antiviral therapy of severe seasonal and avian influenza Antiviral Res. 78, 91-102
15. Leyssen, P., De Clercq, E., and Neyts, J. (2008) Molecular strategies to inhibit the replication of RNA viruses Antiviral Res. 78, 9-25
16. Boltz, D. A., Aldridge, J. R., Jr., Webster, R. G., and Govorkova, E. A. (2010) Drugs in development for influenza Drugs 70, 1349-1362
17. Das, K., Aramini, J. M., Ma, L. C., Krug, R. M., and Arnold, E. (2010) Structures of influenza A proteins and insights into antiviral drug targets Nat. Struct. Mol. Biol. 17, 530-538
18. Hooker, L., Strong, R., Adams, R., Handa, B., Merrett, J. H., Martin, J. A., and Klumpp, K. (2001) A sensitive, single-tube assay to measure the enzymatic activities of influenza RNA polymerase and other poly(A) polymerases: application to kinetic and inhibitor analysis Nucleic Acids Res. 29, 2691-2698 (Pubitemid 32685031)
19. Honda, A., Ueda, K., Nagata, K., and Ishihama, A. (1987) Identification of the RNA polymerase-binding site on genome RNA of influenza virus J. Biochem. 102, 1241-1249
20. Hsu, M. T., Parvin, J. D., Gupta, S., Krystal, M., and Palese, P. (1987) Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle Proc. Natl. Acad. Sci. U.S.A. 84, 8140-8144
21. Seong, B. L. and Brownlee, G. G. (1992) Nucleotides 9 to 11 of the influenza A virion RNA promoter are crucial for activity in vitro J. Gen. Virol. 73, 3115-3124 (Pubitemid 23014161)
22. Dias, A., Bouvier, D., Crépin, T., McCarthy, A. A., Hart, D. J., Baudin, F., Cusack, S., and Ruigrok, R. W. (2009) The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit Nature 458, 914-918
23. Crépin, T., Dias, A., Palencia, A., Swale, C., Cusack, S., and Ruigrok, R. W. (2010) Mutational and metal binding analysis of the endonuclease domain of the influenza virus polymerase PA subunit J. Virol. 84, 9096-9104
24. Tomassini, J. E., Davies, M. E., Hastings, J. C., Lingham, R., Mojena, M., Raghoobar, S. L., Singh, S. B., Tkacz, J. S., and Goetz, M. A. (1996) A novel antiviral agent which inhibits the endonuclease of influenza viruses Antimicrob. Agents Chemother. 40, 1189-1193 (Pubitemid 26141396)
25. Zhao, C., Lou, Z., Guo, Y., Ma, M., Chen, Y., Liang, S., Zhang, L., Chen, S., Li, X., Liu, Y., Bartlam, M., and Rao, Z. (2009) Nucleoside monophosphate complex structures of the endonuclease domain from the influenza virus polymerase PA subunit reveal the substrate binding site inside the catalytic center J. Virol. 83, 9024-9030
26. Yuan, P., Bartlam, M., Lou, Z., Chen, S., Zhou, J., He, X., Lv, Z., Ge, R., Li, X., Deng, T., Fodor, E., Rao, Z., and Liu, Y. (2009) Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site Nature 458, 909-913
27. Plotch, S. J., Bouloy, M., Ulmanen, I., and Krug, R. M. (1981) A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription Cell 23, 847-858 (Pubitemid 11156997)
28. Gilligay, D., Tarendeau, F., Resa-Infante, P., Coloma, R., Crepin, T., Sehr, P., Lewis, J., Ruigrok, R. W., Ortin, J., Hart, D. J., and Cusack, S. (2008) The structural basis for cap binding by influenza virus polymerase subunit PB2 Nat. Struct. Mol. Biol. 15, 500-506 (Pubitemid 351653591)
29. Tomassini, J., Selnick, H., Davies, M. E., Armstrong, M. E., Baldwin, J., Bourgeois, M., Hastings, J., Hazuda, D., Lewis, J., McClements, W., Ponticello, G., Radzilowski, E., Smith, G., Tebben, A., and Wolfe, A. (1994) Inhibition of Cap (M(7)GPPPXM)-dependent endonucelase of influenza-virus by 4-subsituted 2,4-dioxobutanoic acid compounds Antimicrob. Agents Chemother. 38, 2827-2837 (Pubitemid 24374443)
30. Hastings, J. C., Selnick, H., Wolanski, B., and Tomassini, J. E. (1996) Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors Antimicrob. Agents Chemother. 40, 1304-1307 (Pubitemid 26141399)
31. Reguera, J., Weber, F., and Cusack, S. (2010) Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription PLoS Pathog. 6 e1001101 DOI: 10.1371/journal.ppat.1001101
32. Su, C. Y., Cheng, T. J., Lin, M. I., Wang, S. Y., Huang, W. I., Lin-Chu, S. Y., Chen, Y. H., Wu, C. Y., Lai, M. M., Cheng, W. C., Wu, Y. T., Tsai, M. D., Cheng, Y. S., and Wong, C. H. (2010) High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity Proc. Natl. Acad. Sci. U.S.A. 107, 19151-19156
33. Bouloy, M., Plotch, S. J., and Krug, R. M. (1978) Globin messenger-RNAs are primers for transcription of influenza viral-RNA in vitro Proc. Natl. Acad. Sci. U.S.A. 75, 4886-4890 (Pubitemid 9056304)
34. Webster, R. G., Salomon, R., Franks, J., Govorkova, E. A., Ilyushina, N. A., Yen, H. L., Hulse-Post, D. J., Humberd, J., Trichet, M., Rehg, J. E., Webby, R. J., and Mann, E. H. (2006) The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04 J. Exp. Med. 203, 689-697
35. Iwai, Y., Takahashi, H., Hatakeyama, D., Motoshima, K., Ishikawa, M., Sugita, K., Hashimoto, Y., Harada, Y., Itamura, S., Odagiri, T., Tashiro, M., Sei, Y., Yamaguchi, K., and Kuzuhara, T. (2010) Anti-influenza activity of phenethylphenylphthalimide analogs derived from thalidomide Bioorg. Med. Chem. 18, 5379-5390
36. Enyedy, I. J., Ling, Y., Nacro, K., Tomita, Y., Wu, X., Cao, Y., Guo, R., Li, B., Zhu, X., Huang, Y., Long, Y. Q., Roller, P. P., Yang, D., and Wang, S. (2001) Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening J. Med. Chem. 44, 4313-4324 (Pubitemid 33131658)
37. Bachovchin, D. A., Mohr, J. T., Speers, A. E., Wang, C., Berlin, J. M., Spicer, T. P., Fernandez-Vega, V., Chase, P., Hodder, P. S., Schurer, S. C., Nomura, D. K., Rosen, H., Fu, G. C., and Cravatt, B. F. (2011) Organic synthesis toward small-molecule probes and drugs special feature: academic cross-fertilization by public screening yields a remarkable class of protein phosphatase methylesterase-1 inhibitors Proc. Natl. Acad. Sci. U.S.A. 108, 6811-6816
38. Carme Mulero, M., Orzaez, M., Messeguer, J., Messeguer, A., Perez-Paya, E., and Perez-Riba, M. (2010) A fluorescent polarization-based assay for the identification of disruptors of the RCAN1-calcineurin A protein complex Anal. Biochem. 398, 99-103
39. Chen, T., Kablaoui, N., Little, J., Timofeevski, S., Tschantz, W. R., Chen, P., Feng, J., Charlton, M., Stanton, R., and Bauer, P. (2009) Identification of small-molecule inhibitors of the JIP-JNK interaction Biochem. J. 420, 283-294
40. Evelyn, C. R., Ferng, T., Rojas, R. J., Larsen, M. J., Sondek, J., and Neubig, R. R. (2009) High-throughput screening for small-molecule inhibitors of LARG-stimulated RhoA nucleotide binding via a novel fluorescence polarization assay J. Biomol. Screening 14, 161-172
41. Fradet-Turcotte, A., Morin, G., Lehoux, M., Bullock, P. A., and Archambault, J. (2010) Development of quantitative and high-throughput assays of polyomavirus and papillomavirus DNA replication Virology 399, 65-76
42. Gradinaru, C. C., Marushchak, D. O., Samim, M., and Krull, U. J. (2010) Fluorescence anisotropy: from single molecules to live cells Analyst 135, 452-459
43. Han, Z., Pinkner, J. S., Ford, B., Obermann, R., Nolan, W., Wildman, S. A., Hobbs, D., Ellenberger, T., Cusumano, C. K., Hultgren, S. J., and Janetka, J. W. (2010) Structure-based drug design and optimization of mannoside bacterial FimH antagonists J. Med. Chem. 53, 4779-4792
44. Harikumar, K. G., Cawston, E. E., and Miller, L. J. (2011) Fluorescence polarization screening for allosteric small molecule ligands of the cholecystokinin receptor Assay Drug Dev. Technol. 9, 394-402
45. Huang, X. and Aulabaugh, A. (2009) Application of fluorescence polarization in HTS assays Methods Mol. Biol. (N. Y.) 565, 127-143
46. Kimple, A. J., Yasgar, A., Hughes, M., Jadhav, A., Willard, F. S., Muller, R. E., Austin, C. P., Inglese, J., Ibeanu, G. C., Siderovski, D. P., and Simeonov, A. (2008) A high throughput fluorescence polarization assay for inhibitors of the GoLoco motif/G-alpha interaction Comb. Chem. High Throughput Screening 11, 396-409 (Pubitemid 351830309)
47. Neher, T. M., Shuck, S. C., Liu, J. Y., Zhang, J. T., and Turchi, J. J. (2010) Identification of novel small molecule inhibitors of the XPA protein using in silico based screening ACS Chem. Biol. 5, 953-965
48. Sharlow, E. R., Leimgruber, S., Yellow-Duke, A., Barrett, R., Wang, Q. J., and Lazo, J. S. (2008) Development, validation and implementation of immobilized metal affinity for phosphochemicals (IMAP)-based high-throughput screening assays for low-molecular-weight compound libraries Nat. Protoc. 3, 1350-1363
49. Thompson, S., Messick, T., Schultz, D. C., Reichman, M., and Lieberman, P. M. (2010) Development of a high-throughput screen for inhibitors of Epstein-Barr virus EBNA1 J. Biomol. Screening 15, 1107-1115
50. Burke, T. J., Loniello, K. R., Beebe, J. A., and Ervin, K. M. (2003) Development and application of fluorescence polarization assays in drug discovery Comb. Chem. High Throughput Screening 6, 183-194 (Pubitemid 36514198)
51. Zhang, J. H., Chung, T. D., and Oldenburg, K. R. (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays J. Biomol. Screening 4, 67-73 (Pubitemid 29278954)
52. Owicki, J. C. (2000) Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer J. Biomol. Screening 5, 297-306
53. Parkes, K. E. B., Ermert, P., Fassler, J., Ives, J., Martin, J. A., Merrett, J. H., Obrecht, D., Williams, G., and Klumpp, K. (2003) Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitors J. Med. Chem. 46, 1153-1164 (Pubitemid 36428221)
54. Roehrl, M. H., Wang, J. Y., and Wagner, G. (2004) A general framework for development and data analysis of competitive high-throughput screens for small-molecule inhibitors of protein-protein interactions by fluorescence polarization Biochemistry 43, 16056-16066 (Pubitemid 40041019)
55. Abad-Zapatero, C. and Metz, J. T. (2005) Ligand efficiency indices as guideposts for drug discovery Drug Discovery Today 10, 464-492
56. Hopkins, A. L., Groom, C. R., and Alex, A. (2004) Ligand efficiency: a useful metric for lead selection Drug Discovery Today 9, 430-431 (Pubitemid 38510559)
57. Liu-Young, G. and Kozal, M. J. (2008) Hepatitis C protease and polymerase inhibitors in development AIDS Patient Care STDS 22, 449-457
58. Summa, V., Petrocchi, A., Bonelli, F., Crescenzi, B., Donghi, M., Ferrara, M., Fiore, F., Gardelli, C., Paz, O. G., Hazuda, D. J., Jones, P., Kinzel, O., Laufer, R., Monteagudo, E., Muraglia, E., Nizi, E., Orvieto, F., Pace, P., Pescatore, G., Scarpelli, R., Stillmock, K., Witmer, M. V., and Rowley, M. (2008) Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection J. Med. Chem. 51, 5843-5855
59. Boyd, V. A., Mason, J., Hanumesh, P., Price, J., Russell, C. J., and Webb, T. R. (2009) 2-substituted-4,5-dihydroxypyrimidine-6-carboxamide antiviral targeted libraries J. Comb. Chem. 11, 1100-1104
60. Hare, S., Gupta, S. S., Valkov, E., Engelman, A., and Cherepanov, P. (2010) Retroviral intasome assembly and inhibition of DNA strand transfer Nature 464, 232-236
61. Johns, B. A. (2010) HIV-1 integrase strand transfer inhibitors Annu. Rep. Med. Chem. 45, 262-276
62. Nakazawa, M., Kadowaki, S. E., Watanabe, I., Kadowaki, Y., Takei, M., and Fukuda, H. (2008) PA subunit of RNA polymerase as a promising target for anti-influenza virus agents Antiviral Res. 78, 194-201
63. Takahashi, K., Furuta, Y., Fukuda, Y., Kuno, M., Kamiyama, T., Kozaki, K., Nomura, N., Egawa, H., Minami, S., and Shiraki, K. (2003) In vitro and in vivo activities of T-705 and oseltamivir against influenza virus Antiviral Chem. Chemother. 14, 235-241 (Pubitemid 37509379)